Americord Yields 60% More CD34+ Stem Cells

Americord Yields 60% More CD34+ Stem Cells, 54% More Cord Blood, and 34% Higher TNC Than Competitors

New York – May 27, 2014 – Americord announced today that its average cord blood stem cell collection statistics beat the cord blood banking industry medians by significant margins across three critical measures. An in-depth analysis of collection samples through March 31, 2014 revealed that Americord collects 60% more CD34+ stem cells, 54% higher volume, and 34% higher total nucleated cells (TNCs) than are typically collected by other private cord blood banks, as reported in a study published in Transfusion, the AABB’s scholarly, peer-reviewed, monthly journal. “From cutting-edge technology to industry-best processing standards, Americord employs every available tool to collect and preserve the largest volume of viable stem cells for our clients,” said Americord CEO Martin Smithmyer. “The results of this analysis prove that our efforts are delivering quantifiable value for parents and creating much greater opportunities for successful stem cell therapy should it be needed in the future.”

One of the current limitations of cord blood therapy is that the volume of stem cells in a typical cord blood collection is insufficient to effectively treat an adult patient (or anyone over approximately 65 pounds on average). To address this issue, Americord has invested significant resources in the development of technologies and procedures that will increase the volume of stem cells that can be collected when a baby is born. Steps Americord takes to optimize the volume of viable stem cells that can be collected from umbilical cord blood, cord tissue, and placenta tissue include the use of the FDA approved Pall collection bag, an expedited medical courier service, and processing in a CLIA Certified, AABB accredited laboratory that follows all of the best practices for processing and storing umbilical cord blood.

Sources:

•  Sun, J., Allison, J., McLaughlin, C., Sledge, L., Waters‐Pick, B., Wease, S., & Kurtzberg, J. (2010). Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion, 50(9), 1980–1987.

The views, statements, and pricing expressed are deemed reliable as of the published date. Articles may not reflect current pricing, offerings, or recent innovations.